For example, it was found that the number of monocytes of patients with severe COVID-19 decreased, particularly of classical monocytes (CD14++CD16-), and that nonclassical monocytes (CD14+CD16++) significantly depleted in samples from COVID-19 patients with ARDS. Here, CD14 is linked to COVID-19.